Category: Abbott Laboratories
A federal judge will decide whether Boston Scientific owes more than $7 billion to Johnson & Johnson over J&J's jilting by Guidant Corp.
Here's a look at some of the top mergers & acquisitions stories for medical device companies this week: Medtronic CEO: 'Covidien deal will help us do for ORs what we've done for cath labs'; Medtronic details shareholder votes for Covidien merger; CardioMEMS, Nevro among top 20 VC-backed healthcare exits of 2014; Medtronic-Covidien merger could close this month; Covidien's Stellarex drug-eluting balloon wins CE Mark
Four medtech companies make CB Insights list of the top 20 venture capital-backed healthcare exits of 2014.
At least 4 medtech exits were significant enough to make the cut for the top 20 venture capital-backed healthcare exits of 2014, according to research firm CB Insights.
Abbott says it closed the $250 million buyout of Topera Medical and its cardiac arrhythmia mapping technology.
Abbott (NYSE:ABT) said yesterday that it closed its acquisition of Topera Medical, paying $250 million up front and placing another unspecified amount on the table in performance-based milestones.
Here's a look at some of the top legal news stories for medical device companies this week: Lawyer says Guidant didn't breach deal with J&J; Ex-Abbott stent liaison alleges retaliation for compliance complaint; Trial date set for Boston Scientific executive's accused killer; Analogic expects fines in BK Medical's Danish bribery beef; SEC dings Bruker in $2.4m China bribery case
A former Abbott Vascular medical liaison alleges that the company fired her after she flagged Abbott for off-label promotion of its Xience stent and pre-approval marketing of its bioresorbable vascular scaffold.